123 related articles for article (PubMed ID: 31902293)
1. Barriers to Healthcare for People Who Inject Drugs: A Survey at a Syringe Exchange Program.
Miller-Lloyd L; Landry J; Macmadu A; Allard I; Waxman M
Subst Use Misuse; 2020; 55(6):896-899. PubMed ID: 31902293
[No Abstract] [Full Text] [Related]
2. Providing reproductive health services for women who inject drugs: a pilot program.
Owens L; Gilmore K; Terplan M; Prager S; Micks E
Harm Reduct J; 2020 Jul; 17(1):47. PubMed ID: 32664931
[TBL] [Abstract][Full Text] [Related]
3. Syringe access and health harms: Characterizing "landscapes of antagonism" in California's Central Valley.
Syvertsen JL; Pollini RA
Int J Drug Policy; 2020 Jan; 75():102594. PubMed ID: 31775079
[TBL] [Abstract][Full Text] [Related]
4. Access to healthcare insurance and healthcare services among syringe exchange program clients in Massachusetts: qualitative findings from health navigators with the iDU ("I do") Care Collaborative.
Stopka TJ; Hutcheson M; Donahue A
Harm Reduct J; 2017 May; 14(1):26. PubMed ID: 28521814
[TBL] [Abstract][Full Text] [Related]
5. Perceived discrimination and injecting risk among people who inject drugs attending Needle and Syringe Programmes in Sydney, Australia.
Wilson H; Brener L; Mao L; Treloar C
Drug Alcohol Depend; 2014 Nov; 144():274-8. PubMed ID: 25236889
[TBL] [Abstract][Full Text] [Related]
6. I could take the judgment if you could just provide the service: non-prescription syringe purchase experience at Arizona pharmacies, 2018.
Meyerson BE; Lawrence CA; Cope SD; Levin S; Thomas C; Eldridge LA; Coles HB; Vadiei N; Kennedy A
Harm Reduct J; 2019 Sep; 16(1):57. PubMed ID: 31533730
[TBL] [Abstract][Full Text] [Related]
7. Healthcare utilisation and disclosure of injecting drug use among clients of Australia's needle and syringe programs.
Islam MM; Topp L; Iversen J; Day C; Conigrave KM; Maher L
Aust N Z J Public Health; 2013 Apr; 37(2):148-54. PubMed ID: 23551473
[TBL] [Abstract][Full Text] [Related]
8. Performance and image enhancing drug injectors' access to needle syringe programs: Responding to a public policy dilemma.
van Beek I; Chronister KJ
Int J Drug Policy; 2015 Sep; 26(9):868-74. PubMed ID: 26118797
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of needle and syringe programs in Tajikistan distributing low dead space needles.
Zule WA; Latypov A; Otiashvili D; Bangel S; Bobashev GV
Harm Reduct J; 2018 Aug; 15(1):44. PubMed ID: 30170604
[TBL] [Abstract][Full Text] [Related]
10. The impact of a 24-hour syringe dispensing machine on a face-to-face needle and syringe program and targeted primary healthcare clinic.
Uthurralt N; McGlinn A; O'Donnell M; Haber PS; Day CA
Aust N Z J Public Health; 2022 Aug; 46(4):524-526. PubMed ID: 35679052
[TBL] [Abstract][Full Text] [Related]
11. Estimating the number of people who inject drugs and syringe coverage in Australia, 2005-2016.
Kwon JA; Iversen J; Law M; Dolan K; Wand H; Maher L
Drug Alcohol Depend; 2019 Apr; 197():108-114. PubMed ID: 30802734
[TBL] [Abstract][Full Text] [Related]
12. Awareness, perception and utilization of a mobile health clinic by people who use drugs.
Grieb SM; Harris R; Rosecrans A; Zook K; Sherman SG; Greenbaum A; Lucas GM; Page KR
Ann Med; 2022 Dec; 54(1):138-149. PubMed ID: 36799361
[TBL] [Abstract][Full Text] [Related]
13. Syringe Service Program Utilization, Barriers, and Preferences for Design in Rural Appalachia: Differences between Men and Women Who Inject Drugs.
Lancaster KE; Cooper HLF; Browning CR; Malvestutto CD; Bridges JFP; Young AM
Subst Use Misuse; 2020; 55(14):2268-2277. PubMed ID: 32748730
[No Abstract] [Full Text] [Related]
14. Factors associated with obtaining sterile syringes from pharmacies among persons who inject drugs in 20 US cities.
Zlotorzynska M; Weidle PJ; Paz-Bailey G; Broz D;
Int J Drug Policy; 2018 Dec; 62():51-58. PubMed ID: 30359873
[TBL] [Abstract][Full Text] [Related]
15. Trust and people who inject drugs: The perspectives of clients and staff of Needle Syringe Programs.
Treloar C; Rance J; Yates K; Mao L
Int J Drug Policy; 2016 Jan; 27():138-45. PubMed ID: 26394538
[TBL] [Abstract][Full Text] [Related]
16. Uptake of needle and syringe program services in the Kyrgyz Republic: Key barriers and facilitators.
Deryabina A; El-Sadr WM
Drug Alcohol Depend; 2017 Oct; 179():180-186. PubMed ID: 28787695
[TBL] [Abstract][Full Text] [Related]
17. Access to and use of health and social services among people who inject drugs in two urban areas of Mozambique, 2014: qualitative results from a formative assessment.
Dengo-Baloi L; Boothe M; Semá Baltazar C; Sathane I; Langa DC; Condula M; Ricardo H; Inguane C; Teodoro E; Gouveia L; Raymond HF; Horth R
BMC Public Health; 2020 Jun; 20(1):975. PubMed ID: 32571365
[TBL] [Abstract][Full Text] [Related]
18. Treatment experiences for skin and soft tissue infections among participants of syringe service programs in North Carolina.
Figgatt MC; Salazar ZR; Vincent L; Carden-Glenn D; Link K; Kestner L; Yates T; Schranz A; Joniak-Grant E; Dasgupta N
Harm Reduct J; 2021 Jul; 18(1):80. PubMed ID: 34330297
[TBL] [Abstract][Full Text] [Related]
19. Stigma at every turn: Health services experiences among people who inject drugs.
Paquette CE; Syvertsen JL; Pollini RA
Int J Drug Policy; 2018 Jul; 57():104-110. PubMed ID: 29715589
[TBL] [Abstract][Full Text] [Related]
20. Uptake into a bedside needle and syringe program for acute care inpatients who inject drugs.
Brooks HL; O'Brien DC; Salvalaggio G; Dong K; Hyshka E
Drug Alcohol Rev; 2019 May; 38(4):423-427. PubMed ID: 31021491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
